US plans shift of Merck COVID treatment to commercial market
© Reuters. FILE PHOTO: A COVID-19 treatment pill, called molnupiravir developed by Merck & Co and Ridgeback Biotherapeutics LP is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS/
Merck, which developed the drug with Ridgeback Biotherapeutics, said in an emailed statement on Wednesday that it needs an updated letter of authorization from the U.S. Food and Drug Administration to allow it to start selling the drug commercially. It has also been linked to potentially transmissable mutations in the COVID-19 virus, according to a study published in the journal Nature last month. Merck said the study was limited and that it is confident in the clinical profile of the drug.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US FDA authorizes Novavax's updated COVID shot By ReutersUS FDA authorizes Novavax's updated COVID shot
Read more »
Malaysia sees greater savings from shift to targeted subsidy system – Bloomberg, citing minister By ReutersMalaysia sees greater savings from shift to targeted subsidy system – Bloomberg, citing minister
Read more »
EV maker Rivian beats Q3 delivery estimates after raising production By ReutersEV maker Rivian beats Q3 delivery estimates after raising production
Read more »
Digital World, Trump's media firm add new termination clause to merger deal By ReutersDigital World, Trump's media firm add new termination clause to merger deal
Read more »
Microsoft CEO testifies at once-in-a-generation US Google antitrust trial By ReutersMicrosoft CEO testifies at once-in-a-generation US Google antitrust trial
Read more »
Wall St set to open lower as yields rise ahead of Powell speech By ReutersWall St set to open lower as yields rise ahead of Powell speech
Read more »